Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 172-178

  Wang, Chuanmin ^a   Tay, Szun Szun ^a   Tran, Giang T ^b   Hodgkinson, Suzanne J ^b   Allen, Richard D M ^a   Hall, Bruce M ^b   McCaughan, Geoffrey W ^c   Sharland, Alexandra F ^a   Bishop, G Alex ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

Alternative activation; Indoleamine dioxygenase; Liver transplantation

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; INTERLEUKIN 4; MANNOSE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION PROFILING; GRAFT REJECTION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIVER TRANSPLANTATION; MACROPHAGE ACTIVATION; MACROPHAGES; MANNOSE-BINDING LECTINS; RATS; RATS, INBRED LEW; RECEPTORS, CELL SURFACE; TISSUE DONORS; TRANSPLANTATION TOLERANCE;

EID: 77951629119     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.11.005     Document Type: Article

References (49)

1. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Ann Rev Immunol 1999, 17:701-738.
2. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
3. Webb D.C., Cai Y., Matthaei K.I., Foster P.S. Comparative roles of IL-4, IL-13, and IL-4R{alpha} in dendritic cell maturation and CD4+ Th2 cell function. J Immunol 2007, 178:219-227.
4. Morris S.C., Orekhova T., Meadows M.J., Heidorn S.M., Yang J.Q., Finkelman F.D. IL-4 induces in vivo production of IFN-gamma by NK and NKT cells. J Immunol 2006, 176:5299-5305.
5. Aoudjehane L., Podevin P., Scatton O., Jaffray P., Dusanter-Fourt I., Feldmann G., et al. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J 2007, 21:1433-1444.
6. Tay S.-S., Plain K.M., Bishop G.A. Role of IL-4 and Th2 responses in allograft rejection and tolerance. Curr Opin Organ Transpl 2009, 14:16-22.
7. Donckier V., Wissing M., Bruyns C., Abramowicz D., Lybin M., Vanderhaeghen M.L., et al. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995, 59:1571-1576.
8. Gao Q.L., Chen N.X., Rouse T.M., Field E.H. The role of interleukin-4 in the induction phase of allogeneic neonatal tolerance. Transplantation 1996, 62:1847-1854.
9. Lakkis F.G., Konieczny B.T., Saleem S., Baddoura F.K., Linsley P.S., Alexander D.Z., et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 1997, 158:2443-2448.
10. Piccotti J.R., Chan S.Y., VanBuskirk A.M., Eichwald E.J., Bishop D.K. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?. Transplantation 1997, 63:619-624.
11. He X.Y., Chen J., Verma N., Plain K., Tran G., Hall B.M. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation 1998, 65:1145-1152.
12. Takeuchi T., Ueki T., Sunaga S., Ikuta K., Iwakura Y., Li B., et al. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the TH1 cytokine mRNA in grafts. Transplantation 1997, 64:152-157.
13. Le Moine A., Flamand V., Demoor F.X., Noel J.C., Surquin M., Kiss R., et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest 1999, 103:1659-1667.
14. Vanbuskirk A.M., Wakely M.E., Orosz C.G. Transfusion of polarized Th2-Like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996, 62:229-238.
15. Wang C., Li J., Cordoba S.P., Tran G., Hodgkinson S.J., Hall B.M., et al. Post-transplant IL-4 treatment converts rat liver allograft tolerance to rejection. Transplantation 2005, 79:1116-1120.
16. Zimmermann F.A., Davies H.S., Knoll P.P., Gokel J.M., Schmidt T. Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation 1984, 37:406-410.
17. den Dulk M., Bishop G.A. Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents. Arch Immunol Ther Exp 2003, 51:29-44.
18. Sriwatanawongsa V., Davies H.F.S., Calne R.Y. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995, 1:428-432.
19. Sun J., McCaughan G.W., Gallagher N.D., Sheil A.G.R., Bishop G.A. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995, 60:233-236.
20. Bishop G.A., Sun J., DeCruz D.J., Rokahr K.L., Sedgwick J.D., Sheil A.G.R., et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996, 156:4925-4931.
21. Rokahr K.L., Sharland A.F., Sun J., Wang C., Sheil A.G.R., Yan Y., et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998, 95:257-263.
22. Jaruga B., Hong F., Sun R., Radaeva S., Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003, 171:3233-3244.
23. Guillot C., Coathalem H., Chetritt J., David A., Lowenstein P., Gilbert E., et al. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis. J Immunol 2001, 166:5225-5235.
24. Hainz U., Jurgens B., Heitger A. The role of indoleamine 2, 3-dioxygenase in transplantation. Transpl Int 2007, 20:118-127.
25. Tran G.T., Carter N., He X.Y., Spicer T.S., Plain K.M., Nicolls M., et al. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4. Int Immunol 2001, 13:1109-1120.
26. Kamada N., Calne R.Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979, 28:47-50.
27. Sun J., McCaughan G.W., Matsumoto Y., Sheil A.G.R., Gallagher N.D., Bishop G.A. Tolerance to rat liver allografts 1. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994, 57:1349-1357.
28. Sharland A.F., Yan Y., Wang C., Bowen D.G., Sun J., Sheil A.G.R., et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 1999, 68:1736-1745.
29. Lam V.W.T., Taylor C.F., Laurence J.M., Wang C., Sharland A.F., McCaughan G.W., et al. Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on Foxp3 and cytokine expression and graft infiltration. Transpl Immunol 2008, 19:20-24.
30. Yan Y., Van der Putten K., Bowen D.G., Painter D.M., Kohar J., Sharland A.F., et al. Postoperative administration of donor B cells induces long-term rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts. Transplantation 2002, 73:1123-1130.
31. Huang W.H., Yan Y., De Boer B., Bishop G.A., House A.K. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Transplantation 2003, 75:368-374.
32. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005, 115:56-65.
33. Wang Y., Wang Y.P., Zheng G., Lee V.W., Ouyang L., Chang D.H., et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007, 72:290-299.
34. Hesse M., Modolell M., La Flamme A.C., Schito M., Fuentes J.M., Cheever A.W., et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism. J Immunol 2001, 167:6533-6544.
35. Hideyoshi T., Nakao A., Bailey R.J., Nalesnik M.R., Kaizu T., Lemoine J.L., et al. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl 2008, 14:346-357.
36. Mellor A.L., Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol Today 1999, 20:469-473.
37. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002, 196:447-457.
38. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., et al. Function of indoleamine 2, 3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006, 36:690-700.
39. Liu H., Liu L., Fletcher B.S., Visner G.A. Sleeping Beauty-based gene therapy with indoleamine 2, 3-dioxygenase inhibits lung allograft fibrosis. FASEB J 2006, 20:2384-2386.
40. Laurence J.M., Wang C., Park E., Buchanan A., Clouston A., Allen R.D.M., et al. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long term survival but does not cause acute rejection. Transplantation 2008, 85:1357-1361.
41. Laurence J.M., Wang C., Zheng M., Cunningham S., Earl J., Tay S.S., et al. Over-expression of indoleamine dioxygenase in rat liver allografts using a high efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl 2009, 15:233-241.
42. Togashi Y., Chamoto K., Wakita D., Tsutsumi N., Iwakura Y., Matsubara N., et al. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide. Cancer Sci 2007, 98:721-725.
43. Kai S., Goto S., Tahara K., Sasaki A., Tone S., Kitano S. Indoleamine 2, 3-dioxygenase is necessary for cytolytic activity of natural killer cells. Scand J Immunol 2004, 59:177-182.
44. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189:1363-1372.
45. Beilke J.N., Kuhl N.R., Kaer L.V., Gill R.G. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005, 11:1059-1065.
46. Yu G., Xu X., Vu M.D., Kilpatrick E.D., Li X.C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006, 203:1851-1858.
47. Yan Y., Shastry S., Richards C., Wang C., Bowen D.G., Sharland A.F., et al. Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol 2001, 166:5258-5264.
48. Okuda T., Ishikawa T., Azhipa O., Ichikawa N., Demetris A.J., Starzl T.E., et al. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation 2002, 74:103-111.
49. Jonsson J.R., Gu W.Y., Vanags D.M., Bishop G.A., McCaughan G.W., Fawcett J., et al. Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transpl 2004, 10:397-403.